139 related articles for article (PubMed ID: 16706365)
1. [The synthesis, characterization and in situ intestinal absorption of different molecular weight scutellarin-PEG conjugates].
Zhou Q; Jiang X; Li K; Fan X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Apr; 23(2):353-6, 387. PubMed ID: 16706365
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization and in situ intestinal absorption of different molecular weight scutellarin-PEG conjugates.
Zhou Q; Jiang X; Li K; Fan X
Pharmazie; 2006 Aug; 61(8):660-3. PubMed ID: 16964704
[TBL] [Abstract][Full Text] [Related]
3. Prodrugs of scutellarin: ethyl, benzyl and N,N-diethylglycolamide ester synthesis, physicochemical properties, intestinal metabolism and oral bioavailability in the rats.
Cao F; Guo JX; Ping QN; Liao ZG
Eur J Pharm Sci; 2006 Dec; 29(5):385-93. PubMed ID: 16997537
[TBL] [Abstract][Full Text] [Related]
4. [Ester prodrug of scutellarin: synthesis, physicochemical property and degradation].
Cao F; Guo JX; Ping QN; Shao Y; Liang J
Yao Xue Xue Bao; 2006 Jul; 41(7):595-602. PubMed ID: 17007349
[TBL] [Abstract][Full Text] [Related]
5. PEG-scutellarin prodrugs: synthesis, water solubility and protective effect on cerebral ischemia/reperfusion injury.
Lu J; Cheng C; Zhao X; Liu Q; Yang P; Wang Y; Luo G
Eur J Med Chem; 2010 May; 45(5):1731-8. PubMed ID: 20117861
[TBL] [Abstract][Full Text] [Related]
6. Effect of ion-pairing and enhancers on scutellarin skin permeability.
Wang M; Fang L; Ren C; Li T
J Pharm Pharmacol; 2008 Apr; 60(4):429-35. PubMed ID: 18380914
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary delivery of scutellarin solution and mucoadhesive particles in rats.
Liu XB; Ye JX; Quan LH; Liu CY; Deng XL; Yang M; Liao YH
Eur J Pharm Biopharm; 2008 Nov; 70(3):845-52. PubMed ID: 18675905
[TBL] [Abstract][Full Text] [Related]
8. Mrp2-related efflux of scutellarin in the intestinal absorption in rats.
Cao F; Zhang H; Guo J; Ping Q
Pharmazie; 2008 Jan; 63(1):75-80. PubMed ID: 18271309
[TBL] [Abstract][Full Text] [Related]
9. Triglyceride-mimetic prodrugs of scutellarin enhance oral bioavailability by promoting intestinal lymphatic transport and avoiding first-pass metabolism.
Wang X; Zhang C; Han N; Luo J; Zhang S; Wang C; Jia Z; Du S
Drug Deliv; 2021 Dec; 28(1):1664-1672. PubMed ID: 34338567
[TBL] [Abstract][Full Text] [Related]
10. [Effect of pravastatin on transportation of scutellarin in mouse liver and its mechanism].
Liu JM; Xiong YQ
Yao Xue Xue Bao; 2011 Mar; 46(3):269-73. PubMed ID: 21626779
[TBL] [Abstract][Full Text] [Related]
11. [Scutellarin starch microspheres' permeability through nasal mucosa of different animals in vitro].
Ye S; Song X; Li C; Ge W; Shi S
Zhongguo Zhong Yao Za Zhi; 2012 Mar; 37(5):663-6. PubMed ID: 22693914
[TBL] [Abstract][Full Text] [Related]
12. [Absorption and transportation characteristics of scutellarin and scutellarein across Caco-2 monolayer model].
You HS; Zhang HF; Dong YL; Chen SY; Wang MY; Dong WH; Xing JF
Zhong Xi Yi Jie He Xue Bao; 2010 Sep; 8(9):863-9. PubMed ID: 20836977
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats.
Huang JM; Weng WY; Huang XB; Ji YH; Chen E
Eur J Drug Metab Pharmacokinet; 2005; 30(3):165-70. PubMed ID: 16250252
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics and metabolites of scutellarin in normal and model rats].
Gao HM; Wang ZM; Tian J
Yao Xue Xue Bao; 2005 Nov; 40(11):1024-7. PubMed ID: 16499088
[TBL] [Abstract][Full Text] [Related]
15. Two major urinary metabolites of scutellarin in rats.
Qiu F; Xia H; Zhang T; Di X; Qu G; Yao X
Planta Med; 2007 Apr; 73(4):363-5. PubMed ID: 17354170
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy.
Wang J; Tan J; Luo J; Huang P; Zhou W; Chen L; Long L; Zhang LM; Zhu B; Yang L; Deng DY
J Nanobiotechnology; 2017 Mar; 15(1):18. PubMed ID: 28249594
[TBL] [Abstract][Full Text] [Related]
17. Critical determinant of intestinal permeability and oral bioavailability of pegylated all trans-retinoic acid prodrug-based nanomicelles: Chain length of poly (ethylene glycol) corona.
Li Z; Han X; Zhai Y; Lian H; Zhang D; Zhang W; Wang Y; He Z; Liu Z; Sun J
Colloids Surf B Biointerfaces; 2015 Jun; 130():133-40. PubMed ID: 25907597
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics of scutellarin and its derivant scutellarin ethyl ester in rats].
Zhu LW; Liu XQ; Feng J; Gao HM; Yi H; Wang ZM; Meng QJ
Zhongguo Zhong Yao Za Zhi; 2013 Oct; 38(19):3373-7. PubMed ID: 24422411
[TBL] [Abstract][Full Text] [Related]
19. Absorption and disposition of scutellarin in rats: a pharmacokinetic explanation for the high exposure of its isomeric metabolite.
Gao C; Chen X; Zhong D
Drug Metab Dispos; 2011 Nov; 39(11):2034-44. PubMed ID: 21810967
[TBL] [Abstract][Full Text] [Related]
20. A new strategy for enhancing the oral bioavailability of drugs with poor water-solubility and low liposolubility based on phospholipid complex and supersaturated SEDDS.
Zhou H; Wan J; Wu L; Yi T; Liu W; Xu H; Yang X
PLoS One; 2013; 8(12):e84530. PubMed ID: 24391965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
